Navigation Menu 

2019 TPA Summer Meeting | Continuing Education Info

2019 Summer Meeting logo
MEETING HOMELOCATIONAGENDAEXHIBITORS & SPONSORS
REGISTERSPEAKERSCE INFOORGANIZATION INFO
The 2019 TPA Summer Meeting will provide up to 12 hours of ACPE-approved continuing education credit for pharmacists and pharmacy technicians. If you have questions about CE, please contact Lucy Adkins at lucy@tnpharm.org or 615-256-3023.

How to Claim CE Credit
Learning Objectives
Daily Agenda
CE Overview


HOW TO CLAIM CONTINUING EDUCATION CREDIT

All credits must be claimed on the TPCE Continuing Education website at tpce.learningexpressce.com. To begin, you will need to click “Login”, or “Create an Account” at the upper-right corner of the screen. Next, under “Pending/Private Programs,” you will enter “Summer2019” into the “To access a private program, enter the registration code here” field. You will then register for the CE for the meeting. After each session that you attend, select the green “Complete Evaluation” button for that session, enter the code you received at the end of the session, then complete the seminar evaluation. These credits will be transmitted to the CPE Monitor automatically. A full transcript of your CE activities can be obtained at www.nabp.net.

If you have any questions on this process, please contact Lucy Adkins at lucy@tnpharm.org

Please note that you must complete all CE requirements and transmit your credit within 60 days of the program.


LEARNING OBJECTIVES
ADDITIONAL INFORMATION WILL BE ADDED AS IT IS RECEIVED

FRIDAY, JUNE 21

National Overview
0.5 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-125-L04-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Identify key strategies the American Pharmacists Association is exploring to advance pharmacists as providers
  • Describe the current legislative landscape in Washington DC

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Identify key strategies the American Pharmacists Association is exploring to advance pharmacists as providers
  • Describe the current legislative landscape in Washington DC

Update from The United States Pharmacopeial Convention
1.5 Contact Hours, Knowledge-Based Activity, UAN: 0575-0000-19-126-L03-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Describe the development and revision process of USP compounding standards
  • Describe the status of revisions to <797> Pharmaceutical Compounding – Sterile Preparations and identify the currently official chapter
  • Describe the purpose and scope of General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings
  • Identify which drugs are classified as hazardous drugs and the containment strategies that may be implemented
  • Describe the sections within General Chapter <800>

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Describe the development and revision process of USP compounding standards
  • Describe the status of revisions to <797> Pharmaceutical Compounding – Sterile Preparations and identify the currently official chapter
  • Describe the purpose and scope of General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings
  • Identify which drugs are classified as hazardous drugs and the containment strategies that may be implemented
  • Describe the sections within General Chapter <800>

Pharmacists Provider Status: Where Are We and Where Are We Going?
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-127-L04-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Identify the current state of pharmacist provider status across the nation
  • Recognize significant legislative initiatives that support and oppose pharmacist provider status across the nation
  • Discuss opportunities and impact of pharmacist provider status on the pharmacy clinician in the management and monitoring of drug therapy, administrative responsibilities, and pharmacy practice issues or concerns

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Identify the current state of pharmacist provider status across the nation
  • Recognize significant legislative initiatives that support and oppose pharmacist provider status across the nation
  • Discuss opportunities and impact of pharmacist provider status on the pharmacy clinician in the management and monitoring of drug therapy, administrative responsibilities, and pharmacy practice issues or concerns

SATURDAY, JUNE 22

TRACK ONE – Tennessee Society of Health-Systems Pharmacists

An Update in the Management of HIT: Incorporating the DOACs
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-128-L01-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Identify patients who are at increased risk for HIT
  • Explain alternative anticoagulation in patients with HIT based on the latest practice guidelines
  • Discuss the emerging role for DOAC in HIT

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Describe HIT as a potential adverse effect of heparin
  • Discuss the reasons for using alternatives to heparin in patients with HIT
  • Identify potential options for treating patients with HIT

Leveraging Big Data to Advance Pharmacy Practice and Improve Outcomes
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-129-L04-P

At the completion of this activity, the PHARMACIST will be able to:

  • Identify areas of opportunity for using novel data sources to better understand and address individual patient needs
  • Recognize public and private data sources that pharmacists can leverage to advance their practice site
  • Recognize the role of social determinants of health in the medication use and patient care processes

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Recognize the value of patient-reported data in the medication use process
  • Describe ways to assist pharmacists and other providers in collecting and assessing social determinants of health data
  • Identify data sources that may complement information available in pharmacy records systems

Cannabidiol: Is the Grass Always Greener?
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-130-L01-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Review origins and suspected mechanisms of action of marijuana and cannabidiol (CBD)
  • Outline current laws and guidelines regarding the use of marijuana and CBD
  • Discuss approved uses of CBD
  • Identify new literature on potential uses of CBD

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Review origins and suspected mechanisms of action of marijuana and cannabidiol (CBD)
  • Highlight current laws and guidelines regarding the use of marijuana and CBD
  • Discuss approved uses of CBD

The Science of AUC Vancomycin Dosing
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-131-L01-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Summarize relevant literature concerning vancomycin dosing
  • Discuss potential advantages of AUC vancomycin dosing
  • Discuss potential disadvantages of AUC vancomycin dosing

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Describe AUC vancomycin dosing

Vancomycin AUC/MIC Dosing
1.0 Contact Hour, Application-Based Activity, UAN: 0575-0000-19-132-L01-P

At the completion of this activity, the PHARMACIST will be able to:

  • Calculate a vancomycin regimen using the AUC/MIC dosing method
  • Analyze different vancomycin regimens for patients

Medication Use in Older Adults: Updates to the Beers Criteria
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-133-L01-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Identify risk factors for potentially inappropriate medication (PIM) use in older adults
  • Describe changes made to the 2019 American Geriatrics Society (AGS) Beers Criteria
  • List medications considered to be PIMs for use in older patients
  • Review practical implications of the 2019 AGS Beers Criteria update updates

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • List medications considered to be PIMs for use in older patients

TRACK TWO – Practice

Using Quality Measures to Your Advantage in a Community Pharmacy
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-134-L04-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Review key pharmacy quality measures that pharmacies can impact now
  • Outline how to best position your pharmacy for success in quality improvement programs and value-based reimbursement opportunities
  • Discuss processes to incorporate quality performance-focused actions into the pharmacy’s workflow process
  • Review methods to help prioritize work so your team can quickly impact measures and become proactive vs. reactive
  • Outline a pharmacy-specific action plan to positively impact performance

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Review key pharmacy quality measures that pharmacies can impact now
  • Outline how to best position your pharmacy for success in quality improvement programs and value-based reimbursement opportunities
  • Discuss processes to incorporate quality performance-focused actions into the pharmacy’s workflow process
  • Review methods to help prioritize work so your team can quickly impact measures and become proactive vs. reactive
  • Outline a pharmacy-specific action plan to positively impact performance

Clinical Pharmacist Reimbursement Options in the Office
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-135-L04-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Define relative value unit and describe its relevance in terms of physician reimbursement
  • Describe different methods of reimbursement for clinical pharmacist services in a primary care setting
  • Given a patient scenario, describe how much a physician and/or pharmacist may be reimbursed for a particular visit or service in a primary care setting

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Define relative value unit and describe its relevance in terms of physician reimbursement
  • Describe different methods of reimbursement for clinical pharmacist services in a primary care setting
  • Given a patient scenario, describe how much a physician and/or pharmacist may be reimbursed for a particular visit or service in a primary care setting

Motivational Interviewing and Adherence
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-136-L04-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Describe some of the reasons patients are challenged with medication adherence
  • Name the primary motivational interviewing (MI) communication principles
  • Recognize the difference in lecturing and engaging your patient in meaningful conversations.

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Describe some of the reasons patients are challenged with medication adherence
  • Name the primary motivational interviewing (MI) communication principles
  • Recognize the difference in lecturing and engaging your patient in meaningful conversations

The ABC’s of CBD
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-137-L01-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Review common indications, dosing, drug interactions, and adverse effects of CBD
  • Discuss the risks and benefits of CBD
  • Outline effective counseling and communications points for patients and prescribers surrounding CBD

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • List common indications for CBD
  • Outline different formulations of CBD

Non-sterile Compounding – Navigating New Standards and Regulations
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-138-L07-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Examine recent updates to United States Pharmacopeia General Chapter <795>
  • Outline USP <795> standards for personnel training and evaluation
  • Compare and contrast criteria for establishing Beyond-use-Dates for nonsterile preparations

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Examine recent updates to United States Pharmacopeia General Chapter <795>
  • Outline USP <795> standards for personnel training and evaluation
  • Compare and contrast criteria for establishing Beyond-use-Dates for nonsterile preparations

Summer 2019 Board of Pharmacy Update
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-139-L03-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • List new and pending regulations of the Tennessee Board of Pharmacy.
  • Identify boundaries between pharmacist and pharmacy technician responsibilities
  • Explain how to practice safely and effectively under Board of Pharmacy Department of Health guidelines and regulations
  • Discuss current trends in pharmacy practice and the relationship to patient safety

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • List new and pending regulations of the Tennessee Board of Pharmacy
  • Identify boundaries between pharmacist and pharmacy technician responsibilities
  • Explain how to practice safely and effectively under Board of Pharmacy Department of Health guidelines and regulations
  • Discuss current trends in pharmacy practice and the relationship to patient safety

TRACK THREE – Clinical

Immunization Update 2019
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-140-L06-P

At the completion of this activity, the PHARMACIST will be able to:

  • Discuss the epidemiology of recent outbreaks of vaccine-preventable diseases in the United States.
  • Identify important recent changes to the immunization schedules for adults and children in the United States.
  • Describe specific immunization recommendations for special populations
  • List promising new vaccines in the development pipeline

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Discuss the epidemiology of recent outbreaks of vaccine-preventable diseases in the United States.
  • Identify important recent changes to the immunization schedules for adults and children in the United States.
  • Describe specific immunization recommendations for special populations
  • List promising new vaccines in the development pipeline

What’s New in Drug Therapy? Recently Approved Agents that Could Change Your Practice
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-141-L01-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Identify newly approved drugs that are most clinically relevant to general practice in 2019
  • Compare and contrast the role, efficacy, and cost of newly approved medications to existing agents.
  • Discuss relevant indications, efficacy, pharmcokinectics, safety, and dosing of new drugs

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • List the primary use of drugs introduced in 2018
  • Identify essential information to assist pharmacists in counseling patients on changes to the therapeutic application(s) of existing drugs

Use of Natural Products: Clinical Case Studies
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-142-L01-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Explain rationale for use of natural products in specific conditions
  • Review literature supporting use in clinical setting
  • Discuss clinical situations in which natural products may be appropriate

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Explain rationale for use of natural products in specific conditions
  • List common natural products
  • Discuss reasons that patients may prefer natural products

SUNDAY, JUNE 23

The State of the State: 2019 Recap of Important Legislative Initiatives
1.0 Contact Hour, Knowledge-Based Activity, UAN: 0575-0000-19-144-L03-P/T

At the completion of this activity, the PHARMACIST will be able to:

  • Identify recently enacted state and federal legislation affecting pharmacy practice.
  • Describe relevant proposed legislation and potential impact on pharmacy practice.
  • Outline ongoing pharmacy-related health policy and patient care initiatives.

At the completion of this activity, the PHARMACY TECHNICIAN will be able to:

  • Identify recently enacted state and federal legislation affecting pharmacy practice.
  • Describe relevant proposed legislation and potential impact on pharmacy practice.
  • Outline ongoing pharmacy-related health policy and patient care initiatives.

Continuing Education Overview

Click here for the Daily Agenda.

FRIDAY GENERAL SESSIONS WILL INCLUDE:

  • Update from USP
    – Elizabeth Miller, PharmD, VP, U.S. Regulatory Affairs and Public Policy, USP
    – Jeanne Sun, PharmD, Compounding Manager, USP
  • National Pharmacy Priorities
    – Brad Tice, PharmD, MBA, FAPhA, APhA President
  • Pharmacists Provider Status: Where Are We and Where Are We Going?
    – Rebecca Snead, RPh, FAPhA, Executive Vice President and Chief Executive Officer, National Alliance of State Pharmacy Associations

SATURDAY TRACK SESSIONS WILL INCLUDE:

  • An Update on the Management of HIT: Incorporating the DOACs 
  • Leveraging Big Data to Advance Pharmacy Practice and Improve Outcomes 
  • Cannabidiol: Is the Grass Always Greener? 
  • The Science of AUC Vancomycin Dosing 
  • Vancomycin AUC/MIC Dosing 
  • Medication Use in Older Adults: Updates to the Beers Criteria
  • Immunization Update 2019
  • New Drug Update
  • Current Billing and Payment Models
  • Using Quality Based Metrics
  • Natural Products in Your Practice
  • CBD in the Community
  • Non-Sterile Compounding and Other Important Updates
  • Board of Pharmacy Update
  • MORE TO COME!

SUNDAY GENERAL SESSIONS WILL INCLUDE:

  • Student Pharmacist Led Session
  • The State of the State: 2019 Recap of Important Legislative Initiatives
    – Micah Cost, PharmD, MS, Executive Director, Tennessee Pharmacists Association
CLICK HERE TO REGISTER!
QUESTIONS?
Please contact Brittany Jernigan at brittany@tnpharm.org or 615-256-3023.